NM_015272.5:c.1341G>A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_015272.5(RPGRIP1L):​c.1341G>A​(p.Leu447Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0222 in 1,591,368 control chromosomes in the GnomAD database, including 502 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.022 ( 55 hom., cov: 32)
Exomes 𝑓: 0.022 ( 447 hom. )

Consequence

RPGRIP1L
NM_015272.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 2.31

Publications

5 publications found
Variant links:
Genes affected
RPGRIP1L (HGNC:29168): (RPGRIP1 like) The protein encoded by this gene can localize to the basal body-centrosome complex or to primary cilia and centrosomes in ciliated cells. The encoded protein has been found to interact with nephrocystin-4. Defects in this gene are a cause of Joubert syndrome type 7 (JBTS7) and Meckel syndrome type 5 (MKS5). [provided by RefSeq, Jun 2016]
RPGRIP1L Gene-Disease associations (from GenCC):
  • Meckel syndrome, type 5
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Joubert syndrome 7
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • COACH syndrome 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with renal defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Meckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 16-53658781-C-T is Benign according to our data. Variant chr16-53658781-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 126275.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.31 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0225 (3421/152252) while in subpopulation SAS AF = 0.0401 (194/4834). AF 95% confidence interval is 0.0355. There are 55 homozygotes in GnomAd4. There are 1639 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 55 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPGRIP1LNM_015272.5 linkc.1341G>A p.Leu447Leu synonymous_variant Exon 11 of 27 ENST00000647211.2 NP_056087.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPGRIP1LENST00000647211.2 linkc.1341G>A p.Leu447Leu synonymous_variant Exon 11 of 27 NM_015272.5 ENSP00000493946.1

Frequencies

GnomAD3 genomes
AF:
0.0225
AC:
3416
AN:
152134
Hom.:
55
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0277
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0204
Gnomad ASJ
AF:
0.0210
Gnomad EAS
AF:
0.0185
Gnomad SAS
AF:
0.0397
Gnomad FIN
AF:
0.00490
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0219
Gnomad OTH
AF:
0.0239
GnomAD2 exomes
AF:
0.0218
AC:
5084
AN:
233538
AF XY:
0.0230
show subpopulations
Gnomad AFR exome
AF:
0.0297
Gnomad AMR exome
AF:
0.0104
Gnomad ASJ exome
AF:
0.0258
Gnomad EAS exome
AF:
0.00815
Gnomad FIN exome
AF:
0.00686
Gnomad NFE exome
AF:
0.0227
Gnomad OTH exome
AF:
0.0259
GnomAD4 exome
AF:
0.0222
AC:
31941
AN:
1439116
Hom.:
447
Cov.:
28
AF XY:
0.0228
AC XY:
16291
AN XY:
715482
show subpopulations
African (AFR)
AF:
0.0298
AC:
987
AN:
33176
American (AMR)
AF:
0.0114
AC:
490
AN:
42962
Ashkenazi Jewish (ASJ)
AF:
0.0261
AC:
673
AN:
25798
East Asian (EAS)
AF:
0.0312
AC:
1231
AN:
39420
South Asian (SAS)
AF:
0.0400
AC:
3375
AN:
84418
European-Finnish (FIN)
AF:
0.00689
AC:
362
AN:
52518
Middle Eastern (MID)
AF:
0.0224
AC:
127
AN:
5668
European-Non Finnish (NFE)
AF:
0.0212
AC:
23271
AN:
1095578
Other (OTH)
AF:
0.0239
AC:
1425
AN:
59578
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
1380
2760
4140
5520
6900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
876
1752
2628
3504
4380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0225
AC:
3421
AN:
152252
Hom.:
55
Cov.:
32
AF XY:
0.0220
AC XY:
1639
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0277
AC:
1152
AN:
41550
American (AMR)
AF:
0.0203
AC:
311
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0210
AC:
73
AN:
3468
East Asian (EAS)
AF:
0.0185
AC:
96
AN:
5190
South Asian (SAS)
AF:
0.0401
AC:
194
AN:
4834
European-Finnish (FIN)
AF:
0.00490
AC:
52
AN:
10604
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0218
AC:
1485
AN:
67996
Other (OTH)
AF:
0.0236
AC:
50
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
166
332
499
665
831
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0212
Hom.:
26
Bravo
AF:
0.0230
Asia WGS
AF:
0.0350
AC:
123
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 15, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Joubert syndrome 7 Benign:2
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Meckel syndrome, type 5 Benign:2
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Kidney disorder Benign:1
Mar 25, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Joubert syndrome Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nephronophthisis 8 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Meckel-Gruber syndrome;C0431399:Joubert syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.35
CADD
Benign
3.8
DANN
Benign
0.68
PhyloP100
2.3
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61743997; hg19: chr16-53692693; API